In 2023, the standardized mortality rate for female breast malignant neoplasms in Germany was reportedly higher than the forecast starting in 2024. From 2024 to 2028, a gradual decline is projected, from 28.8 to 27.6 female deaths per hundred thousand women, reflecting approximately a 1% annual decrease. This decrease indicates a steady but modest improvement in survival rates or prevention strategies over these years.
Future trends to watch include advancements in medical treatments, early detection technologies, and lifestyle changes that could accelerate this positive downward trend. The impact of healthcare policy and public health initiatives could also play a crucial role in further reducing mortality rates.
